Olaf Oberschmidt

677 total citations
19 papers, 580 citations indexed

About

Olaf Oberschmidt is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Olaf Oberschmidt has authored 19 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Olaf Oberschmidt's work include CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (5 papers). Olaf Oberschmidt is often cited by papers focused on CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (5 papers). Olaf Oberschmidt collaborates with scholars based in Germany, United States and Ireland. Olaf Oberschmidt's co-authors include Ulrike Koehl, Stephan Kloeß, Katja Strohfeldt, Matthias Tacke, Nigel J. Sweeney, Ulrike Eismann, Tanja Gardlowski, Axel Schambach, Michael Morgan and Lubomir Arseniev and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Immunology and Plant Molecular Biology.

In The Last Decade

Olaf Oberschmidt

19 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olaf Oberschmidt Germany	12	408	245	146	114	88	19	580
Pingyu Ding United States	10	164 0.4×	332 1.4×	163 1.1×	114 1.0×	40 0.5×	14	625
Grazia Carbotti Italy	12	321 0.8×	309 1.3×	217 1.5×	58 0.5×	50 0.6×	15	639
Aiping Young Canada	14	181 0.4×	149 0.6×	311 2.1×	157 1.4×	29 0.3×	26	712
Peter Maimonis United States	11	294 0.7×	159 0.6×	331 2.3×	32 0.3×	41 0.5×	19	599
Rita M. Steeves United States	6	327 0.8×	183 0.7×	237 1.6×	74 0.6×	66 0.8×	10	643
M. Roelvink United Kingdom	10	397 1.0×	410 1.7×	225 1.5×	24 0.2×	39 0.4×	16	737
Heather Kostner United States	7	413 1.0×	102 0.4×	263 1.8×	38 0.3×	38 0.4×	12	624
Michel Kraemer France	9	232 0.6×	82 0.3×	147 1.0×	36 0.3×	36 0.4×	13	390
Suzanne J. Bakewell United States	10	282 0.7×	52 0.2×	184 1.3×	94 0.8×	55 0.6×	19	520
Lucile Astorgues‐Xerri France	14	290 0.7×	372 1.5×	666 4.6×	77 0.7×	47 0.5×	30	959

Countries citing papers authored by Olaf Oberschmidt

Since Specialization

Citations

This map shows the geographic impact of Olaf Oberschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Oberschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Oberschmidt more than expected).

Fields of papers citing papers by Olaf Oberschmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf Oberschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Oberschmidt. The network helps show where Olaf Oberschmidt may publish in the future.

Co-authorship network of co-authors of Olaf Oberschmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Oberschmidt. A scholar is included among the top collaborators of Olaf Oberschmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Oberschmidt. Olaf Oberschmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Kloeß, Stephan, Olaf Oberschmidt, Arnold Kloos, et al.. (2019). Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer–Based “Off-the-Shelf” Acute Myeloid Leukemia Immunotherapies. Human Gene Therapy. 30(4). 381–401. 44 indexed citations

Oberschmidt, Olaf, Michael Morgan, Volker Huppert, et al.. (2019). Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering. Human Gene Therapy Methods. 30(3). 102–120. 55 indexed citations

Klöß, Stephan, Olaf Oberschmidt, Michael Morgan, et al.. (2017). Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells. Human Gene Therapy. 28(10). 897–913. 111 indexed citations

Oberschmidt, Olaf, Stephan Kloeß, & Ulrike Koehl. (2017). Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment. Frontiers in Immunology. 8. 654–654. 52 indexed citations

Kloeß, Stephan, Olaf Oberschmidt, Tanja Gardlowski, et al.. (2017). Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset. Frontiers in Immunology. 8. 1100–1100. 7 indexed citations

Sundarasetty, Bala Sai, Stephan Kloeß, Olaf Oberschmidt, et al.. (2015). Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation. Journal of Translational Medicine. 13(1). 240–240. 13 indexed citations

Hanauske, Axel-Rainer, Olaf Oberschmidt, Hartmut M. Hanauske‐Abel, Michael Lahn, & Ulrike Eismann. (2007). Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in vitro soft-agar cloning experiments. Investigational New Drugs. 25(3). 205–210. 30 indexed citations

Beckhove, Philipp, Olaf Oberschmidt, Axel R. Hanauske, et al.. (2007). Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice. Anti-Cancer Drugs. 18(3). 311–315. 50 indexed citations

Hanauske, Axel-Rainer, Ulrike Eismann, Olaf Oberschmidt, et al.. (2007). Correlations of mRNA expression and in vitro chemosensitivity to enzastaurin in freshly explanted human tumor cells. Investigational New Drugs. 26(3). 215–222. 3 indexed citations

10.

Hanauske, Axel-Rainer, Ulrike Eismann, Olaf Oberschmidt, et al.. (2007). In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression. Investigational New Drugs. 25(5). 417–423. 74 indexed citations

11.

Oberschmidt, Olaf, Axel R. Hanauske, Clara Pampillón, et al.. (2007). Antiproliferative activity of Titanocene Y against tumor colony-forming units. Anti-Cancer Drugs. 18(3). 317–321. 45 indexed citations

12.

Eismann, Ulrike, et al.. (2006). Thymidylate synthase gene expression in solid tumors predicts for response to pemetrexed in vitro. Journal of Clinical Oncology. 24(18_suppl). 13058–13058. 7 indexed citations

13.

Oberschmidt, Olaf, Ulrike Eismann, Michael Lahn, et al.. (2006). In vitro chemosensitivity against enzastaurin correlates with gene expression of IL8 and GSK3-beta. Journal of Clinical Oncology. 24(18_suppl). 13046–13046. 1 indexed citations

14.

Oberschmidt, Olaf, Axel‐R. Hanauske, Franz‐Josef K. Rehmann, et al.. (2005). Activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride against tumor colony-forming units. Anti-Cancer Drugs. 16(10). 1071–1073. 42 indexed citations

15.

Eismann, Ulrike, et al.. (2005). Pemetrexed: mRNA expression of the target genes TS, GARFT and DHFR correlates with the in vitro chemosensitivity of human solid tumors. International Journal of Clinical Pharmacology and Therapeutics. 43(12). 567–569. 9 indexed citations

16.

Oberschmidt, Olaf, et al.. (2005). Enzastaurin and pemetrexed exert synergistic antitumor activity in thyroid cancer cell lines in vitro.. PubMed. 43(12). 603–4. 15 indexed citations

17.

Oberschmidt, Olaf, Ulrike Eismann, J. Blatter, et al.. (2004). Pemetrexed: Target gene expression in human solid tumors correlates with chemosensitivity patterns. Journal of Clinical Oncology. 22(14_suppl). 3128–3128. 1 indexed citations

18.

Oberschmidt, Olaf, Florian M. W. Grundler, & Michael Kleine. (2003). Identification of a putative cation transporter gene from sugar beet (Beta vulgaris L.) by DDRT-PCR closely linked to the beet cyst nematode resistance gene Hs1pro-1. Plant Science. 165(4). 777–784. 5 indexed citations

19.

Oberschmidt, Olaf, et al.. (1995). Diurnal Lhc gene expression is present in many but not all species of the plant kingdom. Plant Molecular Biology. 27(1). 147–153. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact